Paydirt
DC
Insider

David Alan Campbell

President and CEO

David Alan Campbell (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in JANX. The largest single filing was $111K of JANX (8,072 sh × $13.73, as filed), executed Jan 2.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$111K
shares × price, as filed
Last traded
Jan 2
Filed Jan 2
Open performance→
Volume by month
$2.4M$1.2M$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2024 · sells $1.3MNov 2024 · sells $1.3MDec 2024 · sells $2.4MJan 2025 · sells $300KJan 2026 · sells $111K
Buys $0 Sells $5.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names
JANX JANX JANX · 0 buys · 7 sells 7 filings
Recent filings
JANXSALE Janux Therapeutics, Inc. View filing → $111K
8,072 sh × $13.73
Exec Jan 2
Filed Jan 2 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $300K
5,000 sh × $60.00
Exec Jan 7 2025
Filed Jan 8 2025 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $1.4M
25,000 sh × $56.19
Exec Dec 24 2024
Filed Dec 27 2024 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $1.0M
15,000 sh × $67.00
Exec Dec 3 2024
Filed Dec 3 2024 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $1.3M
25,000 sh across 2 lots
Exec Nov 25 2024
Filed Nov 27 2024 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $1.3M
25,000 sh across 2 lots
Exec Oct 28 2024
Filed Oct 30 2024 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $1.1M
24,205 sh across 2 lots
Exec Sep 27 2024
Filed Sep 27 2024 · 5:30 PM ET